@yachmod @douglas_ingram Can’t shake the feeling that next announcement is FDA has put a hold on Elividis. I truly hope my feelings are misplaced. At this point I’m a bit shell shocked from the price action.
@Gantosj FDA pretty much telegraphed 4-5 year range, specifically mentioned needing more time to develop labeling requirements.
Assuming good Phase 3 data, what do you think the time frame would be for a FDA decision on the other age groups?